drugset / Trial / NCT00088582
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients
RandomizedCrossoverOpen-labelTreatment
Summary
5 month study comparing SOM230 s.c. and Sandostatin s.c. in acromegalic patients.
Timeline
- Start
- 2004-03
- Primary completion
- 2005-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Octreotide | Peptide | 100 ug | Subcutaneous |
| Subject | Pasireotide | Other / unclassified | 200 ug | Subcutaneous |
| Subject | Pasireotide | Other / unclassified | 400 ug | Subcutaneous |
| Subject | Pasireotide | Other / unclassified | 600 ug | Subcutaneous |